ãå»è ããã«LINEã§ç¸è«ã§ãããµã¼ãã¹ãLINEãã«ã¹ã±ã¢ãããæ©ã人ã«å¯¾ãã¦ãæ»ã¬ã®ãæ£è§£ããä½ã¬ãã«ããã¬ãã³ãã§ãã¨è¨ãæ¾ã¤æ§åãSNSã§æ¡æ£ãçä¸ã8æ2æ¥ä»ãã§LINEãã«ã¹ã±ã¢ããã客æ§ã®ãå¿ãå·ã¤ããå¤å¤§ãªããè¿·æãããããã¾ãããã¨ãæ·±ããè©«ã³ç³ãä¸ãã¾ããã¨è¬ç½ªãã¾ããã LINEãã«ã¹ã±ã¢ã¯ããå°éæ§ãæã£ãå»å¸«ãç¸è«ã«çãããã®ãç¹å¾´ãç¾å¨ã¯COVID-19ï¼æ°åã³ããã¦ã¤ã«ã¹ææçï¼ã®æ¡å¤§é²æ¢ã«åãã¦ãæééå®ã§ç¡åã§ã®ãµã¼ãã¹æä¾ãè¡ã£ã¦ãã¾ãããé常ã¯ããã¾ããç¸è«ãã/ ç¸è«ãäºç´ãããã30å2000åã1000æå以å ã®è³ªåã«å¯¾ãã¦ããã¨ããåçãããããã1000åã®ææãµã¼ãã¹ã§ãã LINEãã«ã¹ã±ã¢ï¼å ¬å¼ãµã¤ãããï¼ ç¾å¨ã¯æééå®ã§ç¡æã§å©ç¨å¯è½ã ã¨ããï¼å ¬å¼ãµã¤ãããï¼ ç©è°ãé¸ãã¦ããã®ã¯ãç¸è«ã®æ§åãæ®å½±ããã¨ããã¹ã¯ãªã¼ã³ã·ã§ããç»åã
{{#tags}}- {{label}}
{{/tags}}